Cite
HARVARD Citation
Mayr, C. et al. (2022). Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. Expert opinion on investigational drugs. pp. 221-233. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mayr, C. et al. (2022). Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. Expert opinion on investigational drugs. pp. 221-233. [Online].